AGPU logo

AXE COMPUTE INC

AGPUNASDAQ
πŸ† #3957 by market capEarnings Nov 12US Equity
$8.66β–Ό $0.24 (βˆ’2.75%)
Latest quote
πŸ””
Track AGPU
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.8%
7dβ–² 11.2%
14dβ–² 3.6%
30dβ–Ό 30.7%
ytdβ–² 22.9%
1yβ–Ό 3.9%
🏦Market Cap
$100M
Small Cap
πŸ“ˆRevenue Growth (YoY)
204.8%
High Growth
πŸ“ŠGross Margin
7.2%
Thin
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
31.0x
Expensive
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$8.65 – $9.04
52-Week Range
$1.03 – $13.49
Volume (shares)
6,921
Avg Volume (shares)
β€”
Shares Outstanding
11.6M
Next Earnings
2026-11-12

Fundamentals Snapshot

Annual Revenue
$125,284
Last Q Revenue
$3M
P/E Ratio
β€”
P/S Ratio
31.0x
EPS (TTM)
$-117.15
Dividend Yield
β€”
Dilution (1yr)
+288.5%
AGPU logo

AXE COMPUTE INC

AGPU
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$125Kβ–Ό βˆ’92.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
42.0%β–Ό βˆ’14.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$28Mβ–² +159.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$42Mβ–² +255.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
21.2Mβ–² +288.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$9Mβ–² +$11M YoY
StockOtter Β· stockotter.space

About AXE COMPUTE INC

Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.